NCT00320034View on ClinicalTrials.gov

Evaluation of the Effect of Levalbuterol on Allergen Induced Airway Inflammation In Subjects With Atopic Asthma

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

June 30, 2008

Study Completion Date

November 30, 2009

Conditions
Asthma
Interventions
DRUG

R-albuterol, S-albuterol

All Listed Sponsors
collaborator

Sumitomo Pharma America, Inc.

INDUSTRY

lead

Hamilton Health Sciences Corporation

OTHER

NCT00320034 - Evaluation of the Effect of Levalbuterol on Allergen Induced Airway Inflammation In Subjects With Atopic Asthma | Biotech Hunter | Biotech Hunter